Can Organ Damage From Schistosomiasis Be Reversed?
At a Glance
Organ damage from schistosomiasis can often be reversed if the infection is treated early. Anti-parasitic medication kills the worms, allowing early-stage liver and bladder inflammation to heal. However, advanced tissue scarring and calcification are usually permanent.
In this answer
3 sections
Yes, in many cases, organ damage caused by schistosomiasis can improve or completely reverse after treatment. The human body has an incredible ability to heal once the underlying cause of damage is removed. Treatment with the standard anti-parasitic medication (praziquantel) effectively kills the adult schistosome worms, which halts the ongoing release of parasite eggs [1][2]. Because the body’s intense inflammatory response is triggered by these eggs, stopping egg production gives your tissues the opportunity to begin the healing process [3].
Note: Because the medication does not kill immature worms, your doctor may recommend a follow-up test or a second dose a few weeks later to ensure all parasites—including those that were maturing during the first dose—are completely eliminated.
Whether your damage completely resolves or leaves permanent scarring depends heavily on how early the infection is treated [4][5]. Your care team will look at your symptoms, blood and urine tests, and an initial ultrasound to determine the stage of your condition and establish a baseline for your recovery [6][7].
Healing in the Liver (Hepatic Schistosomiasis)
When schistosomiasis affects the liver (typically caused by Schistosoma mansoni or Schistosoma japonicum), parasite eggs become trapped in small blood vessels, causing inflammation and a type of scarring known as periportal fibrosis [5][3].
- Early-stage damage is often reversible: If caught early, mild scarring and liver inflammation can shrink significantly or disappear entirely after treatment [5][4]. Studies show that eliminating the parasite can reduce the presence of early periportal fibrosis by an estimated 52% [5]. Pro tip: Avoiding alcohol while recovering gives your liver the best environment to heal.
- Advanced scarring may be permanent: If the infection goes untreated for many years, the liver can develop severe, rigid scarring known as Symmers’ pipestem fibrosis [4][8]. This advanced structural change is permanent and will not reverse with anti-parasitic medication alone [9][10].
- Living with permanent damage: Permanent scarring is not an immediate death sentence for your liver. If you have advanced fibrosis, your doctor will monitor you for complications like portal hypertension (high blood pressure in the liver’s veins) [6]. This can be effectively managed with daily medications (like beta-blockers) or routine screening procedures to prevent bleeding [11][12]. Even with permanent damage, taking the anti-parasitic medication is vital because it stops the disease from getting worse [13].
Healing in the Bladder (Urogenital Schistosomiasis)
When the infection targets the urinary system (caused by Schistosoma haematobium), eggs accumulate in the bladder and urinary tract [14].
- Early-stage damage is highly reversible: Abnormalities such as bladder wall thickening (inflammation and swelling of the bladder tissue) and early urinary tract lesions often heal very well once the parasite is eliminated [14][15]. Pro tip: Drinking plenty of water helps flush the urinary tract and supports recovery.
- Calcification is usually permanent: In chronic infections, continuous tissue damage can cause the bladder wall to develop hardened, calcified patches [16]. These established calcifications are irreversible and remain visible on imaging for years [16][17].
- Living with permanent damage: Having calcification means your bladder has endured long-term stress, which slightly increases the risk of bladder complications, including a specific type of bladder cancer [18][19]. Because of this, you will need long-term medical care, including routine screenings, to catch and manage any future issues early [19].
The Role of Follow-up Ultrasounds
Organ healing is a slow process that happens over months or years, not overnight [20]. Because of this, your doctor will likely schedule a follow-up ultrasound—typically between 6 to 12 months after your treatment—to check on your recovery.
An ultrasound is a painless imaging test that lets your care team measure changes in your tissues. It is an essential tool for seeing if your liver fibrosis or bladder wall thickening is shrinking [20][21]. Tracking these changes helps your doctor update your prognosis and ensures you get the right long-term care for any remaining scarring [22].
Common questions in this guide
Does liver damage from schistosomiasis go away?
Will my bladder fully recover from schistosomiasis?
How does my doctor know if my organs are healing?
Do I need a second dose of schistosomiasis medication?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my initial ultrasound, blood tests, and symptoms, what stage is my liver or bladder damage currently in?
- 2.Do my results show signs of active inflammation that might reverse, or established calcification and pipestem fibrosis that could be permanent?
- 3.Are there any specific lifestyle changes I should make, like adjusting my diet or avoiding certain medications, to support my organ's healing process?
- 4.Given the stage of my damage, do I need specialized screenings for complications like portal hypertension or bladder abnormalities?
- 5.When exactly should we schedule my first follow-up ultrasound to check my healing progress?
- 6.Will I need a follow-up stool or urine test in a few weeks to make sure any immature worms that survived the first treatment are completely gone?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (22)
- 1
Hepatic schistosomiasis with massive splenomegaly: a case report and literature review.
Thijs L, Messiaen P, van der Hilst J, et al.
Acta gastro-enterologica Belgica 2018; (81(1)):93-96.
PMID: 29562382 - 2
A cross-sectional study of periportal fibrosis and Schistosoma mansoni infection among school-aged children in a hard-to-reach area of Madagascar.
Russell HJ, Penney JMS, Linder C, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene 2020; (114(4)):315-322 doi:10.1093/trstmh/traa009.
PMID: 32181487 - 3
Association of CX3CL1 and CX3CR1 Expression with Liver Fibrosis in a Mouse Model of Schistosomiasis.
Zhang P, Wang BJ, Wang JZ, et al.
Current medical science 2020; (40(6)):1121-1127 doi:10.1007/s11596-020-2294-x.
PMID: 33428140 - 4
Baseline Liver Ultrasound Findings in Preschool Children From the Praziquantel in Preschoolers Trial in Lake Albert, Uganda.
Pach S, Webb EL, Edielu A, et al.
The Pediatric infectious disease journal 2024; (43(1)):14-20 doi:10.1097/INF.0000000000004119.
PMID: 37922490 - 5
Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis.
Andrade G, Bertsch DJ, Gazzinelli A, King CH
PLoS neglected tropical diseases 2017; (11(2)):e0005372 doi:10.1371/journal.pntd.0005372.
PMID: 28212414 - 6
Ultrasonographic findings in Schistosoma mekongi infection. A minireview.
Richter J, Kling K, Hatz C, Neumayr A
Parasitology international 2026; (110()):103138 doi:10.1016/j.parint.2025.103138.
PMID: 40774376 - 7
Noninvasive predictors of esophageal varices in patients with hepatosplenic schistosomiasis mansoni.
Nardelli MJ, Veiga ZDST, Faria LC, et al.
Acta tropica 2022; (226()):106283 doi:10.1016/j.actatropica.2021.106283.
PMID: 34919950 - 8
New index for the diagnosis of liver fibrosis in Schistosomiasis mansoni.
Barreto AV, Alecrim VM, Medeiros TB, et al.
Arquivos de gastroenterologia 2017; (54(1)):51-56 doi:10.1590/S0004-2803.2017v54n1-10.
PMID: 28079240 - 9
Ultrasonography of gallbladder abnormalities due to schistosomiasis.
Richter J, Azoulay D, Dong Y, et al.
Parasitology research 2016; (115(8)):2917-24 doi:10.1007/s00436-016-5116-0.
PMID: 27169865 - 10
Naringenin attenuates liver injury in Schistosoma mansoni-induced liver fibrosis and oxidative stress in mice model.
Liang TR, Liu CZ, Peng SY
PLoS neglected tropical diseases 2025; (19(12)):e0013825 doi:10.1371/journal.pntd.0013825.
PMID: 41417851 - 11
PORTAL PRESSURE DECREASE AFTER ESOPHAGOGASTRIC DEVASCULARIZATION AND SPLENECTOMY IN SCHISTOSOMIASIS: LONG-TERM VARICES BEHAVIOR, REBLEEDING RATE, AND ROLE OF ENDOSCOPIC TREATMENT.
Silva Neto WBD, Tredicci TM, Coelho FF, et al.
Arquivos de gastroenterologia 2018; (55(2)):170-174 doi:10.1590/S0004-2803.201800000-30.
PMID: 30043868 - 12
Carvedilol versus propranolol in the prevention of variceal rebleeding in hepatosplenic schistosomiasis: Efficacy and safety.
Razafindrazoto CI, Razafindrabekoto LDE, Hasina Laingonirina DH, et al.
JGH open : an open access journal of gastroenterology and hepatology 2022; (6(3)):213-218 doi:10.1002/jgh3.12721.
PMID: 35355675 - 13
Hepatic schistosomiasis as a determining factor in the development of hepatic granulomas and liver fibrosis: a review of the current literature.
R LC, P F CM, M UE, V J BB
Pathogens and global health 2024; (118(7-8)):529-537 doi:10.1080/20477724.2024.2400033.
PMID: 39268619 - 14
Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial.
Barda B, Coulibaly JT, Hatz C, Keiser J
PLoS neglected tropical diseases 2017; (11(2)):e0005400 doi:10.1371/journal.pntd.0005400.
PMID: 28222149 - 15
Case-Control Study of Posttreatment Regression of Urinary Tract Morbidity Among Adults in Schistosoma haematobium-Endemic Communities in Kwale County, Kenya.
Magak P, Chang-Cojulun A, Kadzo H, et al.
The American journal of tropical medicine and hygiene 2015; (93(2)):371-6 doi:10.4269/ajtmh.15-0153.
PMID: 26013375 - 16
Case report: Radiographic and cystoscopic manifestations of chronic urogenital Schistosomiasis in an asymptomatic Zimbabwean man with HIV.
Kaur H, Alkayali T, Williams N, Schmalzle SA
Urology case reports 2026; (65()):103340 doi:10.1016/j.eucr.2026.103340.
PMID: 41584787 - 17
Seldom Differential of Dysuria in Northern America.
Degheili JA, El-Asmar JM, Moussally M, et al.
Cureus 2019; (11(11)):e6066 doi:10.7759/cureus.6066.
PMID: 31827995 - 18
Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer.
Dematei A, Fernandes R, Soares R, et al.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2017; (125(12)):1056-1062 doi:10.1111/apm.12756.
PMID: 28960560 - 19
The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period.
Yohana C, Bakuza JS, Kinung'hi SM, et al.
Infectious agents and cancer 2023; (18(1)):10 doi:10.1186/s13027-023-00491-1.
PMID: 36800971 - 20
Schistosomiasis Morbidity Hotspots: Roles of the Human Host, the Parasite and Their Interface in the Development of Severe Morbidity.
Mawa PA, Kincaid-Smith J, Tukahebwa EM, et al.
Frontiers in immunology 2021; (12()):635869 doi:10.3389/fimmu.2021.635869.
PMID: 33790908 - 21
Dynamics in Morbidity Markers and Cytological Observations Made in Urine of Schistosoma haematobium-Infected Children: Pre- and Post-Praziquantel Treatment in an Endemic Setting.
Tetteh-Quarcoo PB, Ampong A, Dayie NTKD, et al.
Medical sciences (Basel, Switzerland) 2022; (10(1)) doi:10.3390/medsci10010014.
PMID: 35225947 - 22
Ultrasound and intestinal lesions in Schistosoma mansoni infection: A case-control pilot study outside endemic areas.
Tamarozzi F, Buonfrate D, Badona Monteiro G, et al.
PloS one 2018; (13(12)):e0209333 doi:10.1371/journal.pone.0209333.
PMID: 30562400
This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider to understand your specific prognosis and organ healing progress.
Get notified when new evidence is published on Schistosomiasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.